After this afternoon's 11.2% surge to $81.61 per share, GE HealthCare Technologies might just keep moving past its target price of $83.88. With an average analyst rating of buy, and target prices from $66.0 to $97.0, the stock's next move is anyone's guess.
GE HealthCare Technologies's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 4.0%. The stock's short ratio is 5.88. At 0.08%, the company's rate of insider ownership does not indicate that management is heavily invested in the corporation.
Another number to watch is the company's rate of institutional share ownership, which now stands at 83.7%. In conclusion, we believe there is mixed market sentiment regarding GE HealthCare Technologies.
Institutions Invested in GE HealthCare Technologies
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2023-09-30 | General Electric Company | 14% | 61,581,302 | $5,025,342,356 |
| 2023-09-30 | Capital Research Global Investors | 11% | 49,943,153 | $4,075,611,168 |
| 2023-09-30 | Vanguard Group Inc | 10% | 44,531,402 | $3,633,985,209 |
| 2023-09-30 | Blackrock Inc. | 6% | 28,494,921 | $2,325,328,123 |
| 2023-09-30 | State Street Corporation | 4% | 18,414,921 | $1,502,749,690 |
| 2023-09-30 | Dodge & Cox Inc | 4% | 17,132,992 | $1,398,137,869 |
| 2023-09-30 | Price (T.Rowe) Associates Inc | 3% | 12,259,394 | $1,000,427,888 |
| 2023-09-30 | FMR, LLC | 2% | 8,585,805 | $700,644,645 |
| 2023-09-30 | Geode Capital Management, LLC | 2% | 7,580,591 | $618,614,154 |
| 2023-09-30 | T. Rowe Price Investment Management, Inc. | 1% | 5,198,215 | $424,200,352 |
